- Motley Fool•10 hours ago
Why Wall Street may be missing the big picture behind Under Armour, Teva Pharmaceutical Industries, and Deere & Company.
- Market Realist•16 hours ago
Teva Pharmaceutical (TEVA) expects to report revenue in the range of $23.8 billion–$24.5 billion in 2017, a modest rise of ~8%–12%.
- Market Realist•18 hours ago
Following the completion of its acquisition of Allergan's Actavis Generics business on August 2, 2016, Teva Pharmaceutical plans to focus on realizing the deal's synergies in 2017.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||35.82 x 1900|
|Ask||36.39 x 100|
|Day's Range||35.67 - 36.19|
|52 Week Range||31.90 - 59.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||511.71|
|Dividend & Yield||1.36 (3.78%)|
|1y Target Est||N/A|